O'Shaughnessy Asset Management, LLC Meridian Bioscience Inc Transaction History

O'Shaughnessy Asset Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$17.46 - $21.61 $1,065 - $1,318	-61 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$18.01 - $28.32 $468 - $736	-26 Reduced 29.89%	61 $1,000
Q1 2021 May 14, 2021	SELL	$19.76 - $29.89 $158 - $239	-8 Reduced 8.42%	87 $2,000
Q4 2020 Feb 11, 2021	SELL	$15.73 - $21.66 $243,327 - $335,058	-15,469 Reduced 99.39%	95 $2,000
Q3 2020 Nov 12, 2020	BUY	$13.54 - $26.41 $717 - $1,399	53 Added 0.34%	15,564 $265,000
Q2 2020 Aug 13, 2020	BUY	$7.84 - $23.29 $121,606 - $361,251	15,511 New	15,511 $362,000
Q4 2019 Feb 12, 2020	SELL	$7.9 - $10.14 $528,912 - $678,883	-66,951 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$9.17 - $12.01 $21,586 - $28,271	-2,354 Reduced 3.4%	66,951 $635,000
Q2 2019 Aug 07, 2019	BUY	$10.88 - $17.6 $32,672 - $52,852	3,003 Added 4.53%	69,305 $821,000
Q1 2019 May 10, 2019	BUY	$15.51 - $17.61 $593,707 - $674,093	38,279 Added 136.6%	66,302 $0
Q4 2018 Feb 12, 2019	BUY	$14.52 - $19.72 $406,893 - $552,613	28,023 New	28,023 $487,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.